Skip to main content
Premium Trial:

Request an Annual Quote

NIH To Award $2M To Study Genetic Variations Linked to HIV Susceptibility and Drug Abuse

NEW YORK (GenomeWeb News) – The National Institutes of Health is seeking proposals for research projects that will study genetic variations linked to susceptibility for HIV-1 infection and AIDS progression among drug-abusing populations, according to a request for applications NIH issued on Friday.
 
According to the RFA, available here, the National Institute on Drug Abuse plans to disburse up to $2 million between four and seven projects that will study how genetic factors may provide “protection from or vulnerability to infection, and how drugs of abuse, medications for drug addiction, and HIV-1 treatment interact with both host and viral genes.”
 
NIH said it will also support research into the effects of viral mutations and recombination associated with drug abuse on host responses to infection, as well as the pharmacogenetics of interactions among HIV-1 treatment medications and either drugs of abuse or therapies used in the treatment of drug addiction. 
 
“The importance of biological and genetic differences between individuals, in addition to specific patterns of substance abuse, in explaining differential susceptibility to HIV-1 infection, differences in disease outcome, and differences in response to [antiretroviral and anti-infective drugs] is largely unknown,” NIH said in the RFA.
 
“A more complete understanding of the molecular mechanisms by which genetic variations provide protection from or vulnerability to infection and disease progression, and how drugs of abuse and medications for drug addiction interact with both host and viral genes is needed.”
 
NIH said it plans to support research involving individuals chronically using addictive substances, or use of appropriate in vitro or in vivo models, “to shed light on our understanding of the role of genetic variation within genes involved in modulating immune function, or genes that are highly expressed in monocyte derived dendritic cells, mucosal cells, or other cells/tissues that may alter an individual’s susceptibility to HIV-1 infection.”
 
NIH also plans to study whether drugs of abuse such as methamphetamine interact with host or viral genetic factors to either increase HIV-1 susceptibility or diminish the host’s ability to internalize pathogens and subsequently activate T cells. 
 
Letters of intent are due Feb. 27 and applications are due March 27.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.